ArticleBMC medical genomics2026
Sporadic cone-rod dystrophy caused by a heterozygous RAB28 p.Ser23Phe pathogenic variant and a de novo 4p16.1p15.33 deletion.
Article in BMC medical genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCone-rod dystrophy (CRD) is an inherited retinal dystrophy characterized by decreased visual acuity, color vision defects, and progressive loss of peripheral vision. RAB28-associated CRD is genetically homogeneous and results from pathogenic variants in the RAB28 gene, which is essential for photoreceptor function. CASE PRESENTATION: Fundus examinations, optical coherence tomography, color vision tests, and full-field electroretinography (ERG) were performed in the proband. Genetic analysis, including clinical exome sequencing (CES), Sanger sequencing and chromosomal microarray (CMA), was conducted to determine the genetic cause in the proband. The patient exhibited significantly reduced visual acuity, severe color vision impairment, macular atrophy, and thinning of the photoreceptor layers. Full-field ERG revealed severely diminished cone responses, while rod responses were mildly reduced. Genetic analysis identified that the heterozygous RAB28 c.68 C > T/p.(Ser23Phe) pathogenic variant was inherited exclusively from the father. Additionally, a 3.4 Mb deletion on chromosome 4p16.1p15.33 was detected only in the proband. Four genes associated with Mendelian diseases, including CLNK (OMIM *611434), HS3ST1 (*603244), NKX3-2 (*602183), and RAB28 (*612994), are located within this deletion region.
conclusionsThis case illustrates a rare combination of a heterozygous RAB28 c.68 C > T/p.(Ser23Phe) pathogenic variant and a de novo 4p16.1p15.33 deletion, which is associated with AR CRD. Although extremely rare, bi-allelic RAB28 pathogenic variants can result from one inherited allele and a de novo deletion in the other.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.